Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

MOSim: bulk and single-cell multilayer regulatory network simulator

  • Monzó, Carolina
  • Martínez-Mira, Carlos
  • Arzalluz-Luque, Ángeles
  • Conesa, Ana
  • Aguerralde-Martin, Maider|||0000-0001-9266-8689
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] As multi-omics sequencing technologies advance, the need for simulation tools capable of generating realistic and diverse (bulk and single-cell) multi-omics datasets for method testing and benchmarking becomes increasingly important. We present MOSim, an R package that simulates both bulk (via mosim function) and single-cell (via sc_mosim function) multi-omics data. The mosim function generates bulk transcriptomics data (RNA-seq) and additional regulatory omics layers (ATAC-seq, miRNA-seq, ChIP-seq, Methyl-seq, and transcription factors), while sc_mosim simulates single-cell transcriptomics data (scRNA-seq) with scATAC-seq and transcription factors as regulatory layers. The tool supports various experimental designs, including simulation of gene co-expression patterns, biological replicates, and differential expression between conditions. MOSim enables users to generate quantification matrices for each simulated omics data type, capturing the heterogeneity and complexity of bulk and single-cell multi-omics datasets. Furthermore, MOSim provides differentially abundant features within each omics layer and elucidates the active regulatory relationships between regulatory omics and gene expression data at both bulk and single-cell levels. By leveraging MOSim, researchers will be able to generate realistic and customizable bulk and single-cell multi-omics datasets to benchmark and validate analytical methods specifically designed for the integrative analysis of diverse regulatory omics data., This work was supported by the Scientific Foundation of the Spanish Association Against Cancer through the project PERME224336TARA and by Instituto de Salud Carlos III through the project AC22/00058 (co-funded by the European Union as part of the Next Generation EU programme and the Recovery and Resilience Mechanism, MRR), both projects under the frame of ERA PerMed (ERAPERMED2022-141 OVA-PDM). This work also received funding from the FP7 STATegra project (agreement no. 306000), the Spanish MINECO (BIO2012-40244), the Spanish MICIN (PID2020-119537RB-100), the Spanish Bioinformatics Institute support (PT17/0009/0015-ISCIII-SGEFI/ERDF), the Scientific Foundation of the Spanish Association Against Cancer (PERME224336TARA), under the frame of ERA PerMed (ERAPERMED2022-141 OVA-PDM), and the European Union's programme Horizon Europe under a Marie Skłodowska-Curie grant (101149931).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

MOREshiny: a user-friendly application for the inference of phenotype-specific multi-omic regulatory networks

  • Aguerralde-Martin, Maider|||0000-0001-9266-8689
  • Tarazona, Sonia|||0000-0001-5346-1407
  • Moldovan-Moldovan, Roxana Andreea
  • Verdú, María
[EN] Deciphering phenotype-specific regulatory mechanisms is key to understanding the molecular basis of complex diseases and traits. However, constructing multi-omic regulatory networks (MO-RNs) is challenging, as it requires integrating heterogeneous omics data, incorporating biological context, and detecting regulatory mechanisms that vary across conditions. The R package MORE (Multi-Omics REgulation) addresses these challenges by applying robust statistical models to infer phenotype-specific regulatory networks from multi-omics data. However, the use of MORE typically requires programming expertise, limiting its accessibility to non-specialist users. To democratize access to advanced multi-omics modeling tools, we present MOREshiny, an interactive web application built on Shiny that extends the module of pathway enrichment analysis and automatically guides the choice of statistical methods. MOREshiny enables users to upload multi-omic data, configure their models, and interpret results through a user-friendly interface-without the need for coding skills. MOREshiny also allows users to download MORE results for their later exploration and study. To demonstrate the utility of MOREshiny, we showcase its functionalities on a multi-omic ovarian cancer dataset to understand regulatory differences between patients who did or did not require chemotherapy., This work was supported by the Scientific Foundation of the Spanish Association Against Cancer [PERME224336TARA] and the Instituto de Salud Carlos III [AC22/00058] (co-funded by the European Union as part of the Next Generation EU programme and the Recovery and Resilience Mechanism, MRR), both under the frame of ERA PerMed [ERAPERMED2022-141 OVA-PDM]; and the Spanish Ministry of Science, Innovation and Universities [PID2023-152976NB-I00, PREP2023-001818]. Funding for open access charge: Universitat Politecnica de Valencia.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

MORE interpretable multi-omic regulatory networks to characterise phenotypes

  • Aguerralde-Martin, Maider|||0000-0001-9266-8689
  • Tarazona, Sonia|||0000-0001-5346-1407
  • Clemente-Císcar, Mónica
  • Conesa, Ana
[EN] Studying phenotype-specific regulatory mechanisms is crucial to understanding the molecular basis of diseases and other complex traits. However, existing approaches for constructing multi-omic regulatory networks MO-RN are scarce, and most cannot integrate diverse omics modalities, incorporate prior biological knowledge, or infer phenotype-specific networks. To address these challenges, we present MORE (Multi-Omics REgulation), a novel R package for inferring multi-modal regulatory networks. MORE is available at https://github.com/BiostatOmics/MORE and supports any number and type of omics layers while optionally incorporating prior regulatory knowledge. Leveraging advanced regression-based models and variable selection techniques, MORE identifies significant regulatory relationships. This tool also provides useful functionalities for the biological interpretation of MO-RN: network visualisations, differential regulatory networks, and functional enrichment analyses of key network features. We evaluated MORE on simulated multi-omic datasets and benchmarked it against state-of-the-art tools. Our tool consistently outperformed other methods regarding accuracy in identifying significant regulators, model goodness-of-fit, and computational efficiency. We further applied MORE to a multi-omic ovarian cancer dataset to uncover tumour subtype-specific regulatory mechanisms associated with distinct survival outcomes. This analysis revealed differential regulatory patterns to understand the molecular basis of each subtype. By addressing the limitations of methods for multi-omic network inference, MORE represents a valuable resource for studying regulatory systems. Its ability to construct phenotype-specific regulatory networks with high accuracy and interpretability positions it as a useful resource for researchers seeking to unravel the complexities of molecular interactions and regulatory mechanisms across diverse biological contexts., This work was supported by the Scientific Foundation of the Spanish Association Against Cancer through the project PERME224336TARA and by Instituto de Salud Carlos III through the project AC22/00058 (co-funded by the European Union as part of the Next Generation EU programme and the Recovery and Resilience Mechanism, MRR), both projects under the frame of ERA PerMed (ERAPERMED2022-141-OVA-PDM). This work also received Funding from the FP7 STATegra project (agreement no. 306000), the Spanish MINECO (BIO2012-40244), and the Spanish MICIN (PID2020-119537RB-100).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Coxmos: interpretable survival models for high-dimensional and multi-omic data

  • Salguero, Pedro
  • Buendía-Galera, Anabel
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Background Survival analysis in high-dimensional (HD) and multi-block (MB) settings, such as omic and multi-omic studies, poses major methodological challenges due to multicollinearity, low events-per-variable ratios, and limited model interpretability. While Cox Proportional Hazards models remain widely used, their applicability is restricted in HD scenarios. Machine learning approaches can handle such complexity but often lack interpretability. Survival models based on Partial Least Squares (PLS) offer an attractive compromise, yet existing implementations provide limited support for model optimization, evaluation, and interpretation.Results To overcome these limitations, we introduce Coxmos, a CRAN R package that integrates adapted Cox regression models with HD-adapted variable selection, and optimized PLS-based approaches tailored for HD and MB data. Coxmos also provides validation, comparison, interpretation, and visualization tools. Benchmarking on a diverse set of clinical, single-omic, and multi-omic cancer datasets - including breast (BRCA), head and neck (HNSC), and ovarian (HGSOC) cancer - demonstrated that Coxmos outperformed other state-of-the-art machine learning methods, while enhancing interpretability. We illustrated the package's functionalities through two case studies (HGSOC and HNSC), showing how Coxmos facilitates model selection, validation, and biological interpretation in a complex HD and MB survival analysis.Conclusions Coxmos provides a robust, flexible, and interpretable solution for survival analysis in HD and MB data. By combining optimized PLS-based methodologies with rigorous evaluation and rich visualization tools, Coxmos enables reliable survival prediction and facilitates the identification of relevant risk and protective factors in complex biomedical studies. The package fills an important methodological gap and represents a valuable resource for reproducible and interpretable survival modeling in the big data scenario., This work was supported by the Scientific Foundation of the Spanish Association Against Cancer through the project PERME224336TARA and by Instituto de Salud Carlos III through the project AC22/00058 (co-funded by the European Union as part of the Next Generation EU programme and the Recovery and Resilience Mechanism, MRR), both projects under the frame of ERA PerMed (ERAPERMED2022-141 - OVA-PDM). This work was also funded by Generalitat Valenciana (ACIF/2019/081), Spanish MICIN (PID2020-119537RB-100), and Spanish MICIU (PID2023-152976NB-I00).